mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.02 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |